Literature DB >> 11918467

Lennox-Gastaut syndrome.

Patricia K Crumrine1.   

Abstract

Lennox-Gastaut syndrome is a type of childhood epilepsy that has enormous detrimental effects on the patient's physical and developmental health and can also take a dramatic toll on the well-being of the patient's family. Lennox-Gastaut syndrome is characterized by variable etiology, multiple types of intractable seizures, and cognitive impairment in most patients. It is one of the most difficult epilepsy syndromes to treat and is frequently resistant to treatment with standard antiepilepsy drugs. This article reviews the etiology of Lennox-Gastaut syndrome, characteristics of predominant seizure types, methods of evaluating patients for Lennox-Gastaut syndrome, and available treatments including antiepilepsy drug therapy, ketogenic diet, and surgical options.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11918467     DOI: 10.1177/08830738020170011001

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  15 in total

Review 1.  Neuroprotective and disease-modifying effects of the ketogenic diet.

Authors:  Maciej Gasior; Michael A Rogawski; Adam L Hartman
Journal:  Behav Pharmacol       Date:  2006-09       Impact factor: 2.293

Review 2.  Lennox-Gastaut syndrome: a comprehensive review.

Authors:  Ali A Asadi-Pooya
Journal:  Neurol Sci       Date:  2017-11-09       Impact factor: 3.307

Review 3.  Clobazam.

Authors:  Yu-tze Ng; Stephen D Collins
Journal:  Neurotherapeutics       Date:  2007-01       Impact factor: 7.620

Review 4.  Sleep and childhood epilepsy.

Authors:  S Aneja; M Gupta
Journal:  Indian J Pediatr       Date:  2005-08       Impact factor: 1.967

5.  [Suggestion for a new, patient-oriented epilepsy classification].

Authors:  C Kellinghaus; T Loddenkemper; E Wyllie; I Najm; A Gupta; F Rosenow; C Baumgartner; F Boesebeck; B Diehl; C Drees; A Ebner; H Hamer; S Knake; J H Meencke; M Merschhemke; G Möddel; S Noachtar; S Rona; S U Schuele; B J Steinhoff; I Tuxhorn; K Werhahn; H O Lüders
Journal:  Nervenarzt       Date:  2006-08       Impact factor: 1.214

Review 6.  Management of seizures in Lennox-Gastaut syndrome.

Authors:  Patricia K Crumrine
Journal:  Paediatr Drugs       Date:  2011-04-01       Impact factor: 3.022

7.  Association of GABAA Receptor Gene with Epilepsy Syndromes.

Authors:  Musadiq Ahmad Bhat; Sameer Ahmad Guru; Rashid Mir; Ajaz Ahmad Waza; Mariyam Zuberi; Mamta Pervin Sumi; Shaam Bodeliwala; Vinod Puri; Alpana Saxena
Journal:  J Mol Neurosci       Date:  2018-05-21       Impact factor: 3.444

Review 8.  Rufinamide.

Authors:  Emma D Deeks; Lesley J Scott
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

9.  Supporting the recommended paediatric dosing regimen for rufinamide in Lennox-Gastaut syndrome using clinical trial simulation.

Authors:  M Marchand; E Fuseau; D J Critchley
Journal:  J Pharmacokinet Pharmacodyn       Date:  2010-02       Impact factor: 2.745

10.  Lennox gastaut syndrome, review of the literature and a case report.

Authors:  Tareq Abu Saleh; Lawrence Stephen
Journal:  Head Face Med       Date:  2008-06-09       Impact factor: 2.151

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.